search
Back to results

Efficacy of Physiotherapy for Urinary Incontinence in Women With a Puborectalis Avulsion

Primary Purpose

Urinary Incontinence, Postpartum, Pelvic Floor; Perineal Rupture, Obstetric

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Multimodal physiotherapy
Sponsored by
Université de Sherbrooke
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Urinary Incontinence focused on measuring avulsion injury, urinary incontinence, multimodal physiotherapy

Eligibility Criteria

18 Years - 45 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • 18-45 years old
  • Postpartum women (≥ 1 vaginal delivery at term (≥ 37 weeks) and ≥ 3 months postpartum
  • ≥ 3 urinary incontinence episodes per week over the last 3 months (Symptoms of incontinence must be associated predominantly or solely with stress urinary incontinence (as opposed to urge incontinence) which will be determined with a recommended and validated diagnosis questionnaire (Questionnaire for Urinary Incontinence Diagnosis))
  • Women with diagnosis avulsion injury

Exclusion Criteria:

  • Pregnancy or postmenopausal
  • Previous pelvic irradiation, urogynecological surgery, or PFM physiotherapy after the avulsion occurred
  • Significant prolapse (≥3 degree)
  • Incontinence due to other causes such as infection, neurological diseases, voiding difficulties
  • Any other acute or chronic medical problems likely to interfere with treatment or evaluation such as cancer, chronic constipation (Rome III criteria), obesity (body mass index >35), pacemaker, bladder stimulator
  • Medication or ongoing treatment likely to interfere with incontinence

Sites / Locations

  • Centre Hospitalier Universitaire de Sherbrooke

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Multimodal physiotherapy

Waiting-list control group

Arm Description

12 weeks of weekly multimodal physiotherapy treatments

12 weeks of weekly full-body relaxation massage

Outcomes

Primary Outcome Measures

Percent reduction in the number of urinary incontinence episodes
The 7-day bladder diary was selected as the primary outcome to measure urinary leakage reduction

Secondary Outcome Measures

Change in symptoms and impact of incontinence and other urogynecological conditions
Evaluated with ICI Modular Questionnaires (ICIQ), Pelvic Floor Distress Inventory (PFDI), Pelvic Floor Impact Questionnaire (PFIQ-SF) and Pelvic Organ Prolapse Symptom score (POP-SS)
Change in pelvic floor muscle morphometry and function
Evaluated with transperineal ultrasound and dynamometry
Change in severity of prolapse
Evaluated with POP-Q assessment
Change in sexual function
Evaluated with Female Sexual Function Index (FSFI) and Pelvic Organ Prolapse/Incontinence Sexual Questionnaire (PISQ-SF)
Change in self-efficacy
Evaluated with Broom Pelvic Muscle Self-Efficacy Scale
Cost analysis
Evaluated with Dowell-Bryant Incontinence Cost Index (DBICI)
Treatment satisfaction and impression of change
Evaluated with Patient Satisfaction Questionnaire (PSQ) and Patient's Global Impression of Change (PGIC)

Full Information

First Posted
August 9, 2017
Last Updated
June 12, 2023
Sponsor
Université de Sherbrooke
Collaborators
Canadian Institutes of Health Research (CIHR)
search

1. Study Identification

Unique Protocol Identification Number
NCT03254355
Brief Title
Efficacy of Physiotherapy for Urinary Incontinence in Women With a Puborectalis Avulsion
Official Title
Efficacy of Physiotherapy for Urinary Incontinence in Women With a Known Avulsion Injury of the Puborectalis Muscle: A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Completed
Study Start Date
August 28, 2017 (Actual)
Primary Completion Date
May 10, 2023 (Actual)
Study Completion Date
May 10, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Université de Sherbrooke
Collaborators
Canadian Institutes of Health Research (CIHR)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Childbirth is a major risk factor for pelvic floor muscle (PFM) trauma. In one third of women, stretching of the PFM will result in an avulsion injury (i.e. disconnection of the muscle from its insertion points on the pubic symphysis). Recent advances in imaging have led to the discovery of this previously unknown major injury and further research now enables its diagnosis with readily available techniques. Avulsion injury has alarming consequences because it has been associated with a higher rate of urinary incontinence in the postpartum period as well as the long-term development of other major urogynecological conditions such as pelvic organ prolapse and anal incontinence. Women with avulsion not only suffer from severe symptoms with significant related impacts on physical activities, overall well-being and quality of life, but they also present a higher rate of surgical failures. Moreover, it is still unknown whether the most recommended first-line treatment for urinary incontinence -PFM physiotherapy- is effective in women with this major trauma. Until now, only a pilot study conducted by our team supports the rationale and the efficacy of physiotherapy for improving PFM function in women with avulsion, despite their major muscle injury. Primary objective: To evaluate the efficacy of physiotherapy for urinary incontinence in women with avulsion at 9-months after randomization compared to a waiting-list control group. Secondary objectives: To compare physiotherapy to the control group after treatment and at 9-months after randomization in terms of: a) incontinence and prolapse (objective quantification, symptoms and related impact); b) PFM morphology and function; c) sexual function; d) self-efficacy; e) cost analysis; f) treatment satisfaction and impression of change. To investigate the impact of the severity of the avulsion (i.e. unilateral or bilateral) on the response to physiotherapy treatment on the aforementioned outcomes.
Detailed Description
This is a multicenter randomized controlled trial using a parallel group design that involves women with a confirmed diagnosis of avulsion and suffering from urinary incontinence. Participants will be randomized into either physiotherapy or a waiting-list control group. Both groups will be evaluated at baseline, post-treatment (3 months post-randomization) and 9 months after randomization. Women in the control group will receive full-body relaxation massage which has shown no effect on continence but was selected to control for effects of attention received by the therapist. After the 9-month assessment, women assigned to the control group will receive the same physiotherapy treatment and undergo a last assessment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urinary Incontinence, Postpartum, Pelvic Floor; Perineal Rupture, Obstetric, Physiotherapy
Keywords
avulsion injury, urinary incontinence, multimodal physiotherapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
126 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Multimodal physiotherapy
Arm Type
Experimental
Arm Description
12 weeks of weekly multimodal physiotherapy treatments
Arm Title
Waiting-list control group
Arm Type
No Intervention
Arm Description
12 weeks of weekly full-body relaxation massage
Intervention Type
Procedure
Intervention Name(s)
Multimodal physiotherapy
Intervention Description
12 weeks of weekly physiotherapy treatments including education segment, electrical stimulation and PFM exercises consisting of strength, endurance and coordination exercises accompanied by biofeedback
Primary Outcome Measure Information:
Title
Percent reduction in the number of urinary incontinence episodes
Description
The 7-day bladder diary was selected as the primary outcome to measure urinary leakage reduction
Time Frame
baseline, post-treatment (3 months post-randomization) and 9 months after randomization
Secondary Outcome Measure Information:
Title
Change in symptoms and impact of incontinence and other urogynecological conditions
Description
Evaluated with ICI Modular Questionnaires (ICIQ), Pelvic Floor Distress Inventory (PFDI), Pelvic Floor Impact Questionnaire (PFIQ-SF) and Pelvic Organ Prolapse Symptom score (POP-SS)
Time Frame
baseline, post-treatment (3 months post-randomization) and 9 months after randomization
Title
Change in pelvic floor muscle morphometry and function
Description
Evaluated with transperineal ultrasound and dynamometry
Time Frame
baseline, post-treatment (3 months post-randomization) and 9 months after randomization
Title
Change in severity of prolapse
Description
Evaluated with POP-Q assessment
Time Frame
baseline, post-treatment (3 months post-randomization) and 9 months after randomization
Title
Change in sexual function
Description
Evaluated with Female Sexual Function Index (FSFI) and Pelvic Organ Prolapse/Incontinence Sexual Questionnaire (PISQ-SF)
Time Frame
baseline, post-treatment (3 months post-randomization) and 9 months after randomization
Title
Change in self-efficacy
Description
Evaluated with Broom Pelvic Muscle Self-Efficacy Scale
Time Frame
baseline, post-treatment (3 months post-randomization) and 9 months after randomization
Title
Cost analysis
Description
Evaluated with Dowell-Bryant Incontinence Cost Index (DBICI)
Time Frame
baseline and 9 months after randomization
Title
Treatment satisfaction and impression of change
Description
Evaluated with Patient Satisfaction Questionnaire (PSQ) and Patient's Global Impression of Change (PGIC)
Time Frame
baseline, post-treatment (3 months post-randomization) and 9 months after randomization

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 18-45 years old Postpartum women (≥ 1 vaginal delivery at term (≥ 37 weeks) and ≥ 3 months postpartum ≥ 3 urinary incontinence episodes per week over the last 3 months (Symptoms of incontinence must be associated predominantly or solely with stress urinary incontinence (as opposed to urge incontinence) which will be determined with a recommended and validated diagnosis questionnaire (Questionnaire for Urinary Incontinence Diagnosis)) Women with diagnosis avulsion injury Exclusion Criteria: Pregnancy or postmenopausal Previous pelvic irradiation, urogynecological surgery, or PFM physiotherapy after the avulsion occurred Significant prolapse (≥3 degree) Incontinence due to other causes such as infection, neurological diseases, voiding difficulties Any other acute or chronic medical problems likely to interfere with treatment or evaluation such as cancer, chronic constipation (Rome III criteria), obesity (body mass index >35), pacemaker, bladder stimulator Medication or ongoing treatment likely to interfere with incontinence
Facility Information:
Facility Name
Centre Hospitalier Universitaire de Sherbrooke
City
Sherbrooke
State/Province
Quebec
ZIP/Postal Code
J1H 5N4
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Efficacy of Physiotherapy for Urinary Incontinence in Women With a Puborectalis Avulsion

We'll reach out to this number within 24 hrs